Reiko Sugiura

18PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesCarbon capture engineering (excl. sequestration)Molecular targetsCell development, proliferation and death
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 15, 2025
Calcium/Calmodulin-Dependent Protein Kinase II Inhibitors Mitigate High-Fat Diet-Induced Obesity in Mice.

Naoyuki Kawao, Ryosuke Satoh, Yuya Mizukami

|Dec 18, 2024
Rapamycin Abrogates Aggregation of Human α-Synuclein Expressed in Fission Yeast via an Autophagy-Independent Mechanism.

Yoshitaka Sugimoto, Teruaki Takasaki, Ryuga Yamada

|May 08, 2024
Rcn1, the fission yeast homolog of human DSCR1, regulates arsenite tolerance independently from calcineurin.

Teruaki Takasaki, Asuka Bamba, Yuka Kukita

|Mar 19, 2024
ACA-28, an ERK MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and Pancreatic Cancer Cells.

Teruaki Takasaki, Yasuyuki Hamabe, Kenta Touchi

|Mar 22, 2023
ACAGT-007a, an anti-cancer compound that modulates ERK MAPK signaling, induces nuclear enrichment of phosphorylated ERK in T3M4 pancreatic cancer cells.

Golam Iftakhar Khandakar, Yoichi Miyamoto, Ryosuke Satoh

|Feb 25, 2022
ACAGT-007a, an ERK MAPK Signaling Modulator, in Combination with AKT Signaling Inhibition Induces Apoptosis in KRAS Mutant Pancreatic Cancer T3M4 and MIA-Pa-Ca-2 Cells.

Golam Iftakhar Khandakar, Ryosuke Satoh, Teruaki Takasaki

Pageof 3

Frequent Collaborators

3 joint publications

Teruaki Takasaki

2 joint publications

Ryosuke Satoh

2 joint publications

Golam Iftakhar Khandakar

1 joint publications

Yuki Kanda